Research progress of CREB in angiogenesis, anti-apoptosis and lung cancer

doi:10.11958/20182109

Tianjin Med J ›› 2019, Vol. 47 ›› Issue (4): 431-435.doi: 10.11958/20182109

• Review • Previous Articles Next Articles

Research progress of CREB in angiogenesis, anti-apoptosis and lung cancer

LIU Xiao, DUAN Yong, ZHANG Yan-liang

Yunnan Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, the First Affiliated Hospital of Kunming Medical University, Yunnan Institute of Experimental Diagnosis, Kunming 650032, China

Received:2018-12-21 Revised:2019-01-15 Published:2019-04-15 Online:2019-05-27
Contact: Xiao Liu E-mail:18088446698@163.com
Supported by:
Expression and Mechanism of CREB3L4 Gene in Xuanwei Lung Cancer in Yunnan Province;The role and molecular mechanism of CREB3L4 in the pathogenesis of lung cancer in Xuanwei, Yunnan

LIU Xiao, DUAN Yong, ZHANG Yan-liang. Research progress of CREB in angiogenesis, anti-apoptosis and lung cancer[J]. Tianjin Med J, 2019, 47(4): 431-435.

Abstract

Abstract: cAMP-response element binding protein (CREB) has been widely studied as a transcriptional factor in the field of long-term memory formation and the development and treatment of various malignant tumors. This review summarized the research progress of CREB gene in neovascularization, cell proliferation and anti-apoptosis, and the relationship between CREB geen and the carcinogenic process of nicotine and tumors (especially lung cancer) in order to provide references for future research of CREB family proteins.

Key words: cyclic AMP response element-binding protein, neovascularization, pathologic, apoptosis, nicotine, lung neoplasms, carcinoma

[1]	YANG Xiaofang, JIA Xinyan, FENG Wenjun. MiR-181a-5p regulates the proliferation and apoptosis of glomerular mesangial cells in lupus nephritis mice through HMGB1/NF-κB signaling pathway [J]. Tianjin Medical Journal, 2026, 54(3): 232-237.
[2]	ZHANG Jing, WEI Yuying, NING Haihong, WEI Hongmei, WANG Jiawei, CAO Wei, WU Bin. Protective effect and mechanism of dual-specificity phosphatase 9 on myocardial injury in mice with type 2 diabetic cardiomyopathy [J]. Tianjin Medical Journal, 2026, 54(3): 238-244.
[3]	ZHU Haiyan, WANG Ye, YIN Yan. Risk factors for postoperative gastrointestinal dysfunction in elderly NSCLC patients [J]. Tianjin Medical Journal, 2026, 54(3): 289-294.
[4]	HUANG Zengyuan, FU Jing, ZHAO Ya, WANG Longhao, CANG Shundong. Research progress on the relationship between EGFR-TKI resistance and p53 mutation in non-small cell lung cancer [J]. Tianjin Medical Journal, 2026, 54(3): 333-336.
[5]	WANG Zhe, QIU Lin, MA Ben. Research on the effect of tomato derived nanovesicles on oral squamous cell carcinoma [J]. Tianjin Medical Journal, 2026, 54(2): 145-150.
[6]	LI Zhiwei, ZHANG Huichao, YANG Fengming, ZENG Chuiyi. Exploring the effect of red ginseng total saponins on cardiomyocyte apoptosis in dilated cardiomyopathy mice based on miR-144-3p/MAPK1 pathway [J]. Tianjin Medical Journal, 2026, 54(1): 23-29.
[7]	ZHAO Lanjun, LI Lianghui, MA Xin, GONG Jiaojiao, ZHENG Chenhui, SHI Lin. The effect of andrographolide regulating STAT3/GPX4 pathway on proliferation and apoptosis of myeloma cells [J]. Tianjin Medical Journal, 2026, 54(1): 8-13.
[8]	KONG Cuiwen, LU Yanshuang, SUN Liping, YU Fenfen. The effect of LncRNA SNHG14 on high glucose induced podocyte injury by targeting miR-30a-5p [J]. Tianjin Medical Journal, 2025, 53(9): 903-909.
[9]	ZHOU Pengpeng, DING Shuo, YAO Weikang, LUO Yi. Preoperative immune factors in patients with primary hepatocellular carcinoma and their relationship with pathological characteristics [J]. Tianjin Medical Journal, 2025, 53(9): 952-956.
[10]	WAN Yanbo, LIU Ming, WANG Yong. The effect of esculin on hypoxia/reoxygenation induced myocardial cell injury by regulating HMGB1/RAGE signaling pathway [J]. Tianjin Medical Journal, 2025, 53(8): 796-801.
[11]	SONG Shanshan, JIANG Min, WANG Liang, HUANG Bozhen, WANG Guoyu, LIU Xinxin, MA Siyi. The global burden of tracheal, bronchial and lung cancer disease from 1990 to 2021 and the forecast to 2040 [J]. Tianjin Medical Journal, 2025, 53(8): 875-883.
[12]	LIU Haiwei, YANG Jie, WANG Li, MENG Shibo, TANG Xusong, LIU Chengren, WANG Yongwang. Luteolin inhibits glioblastoma by regulating ROS levels via the NFE2L2/x-CT/GPX4 signalling axis [J]. Tianjin Medical Journal, 2025, 53(7): 673-678.
[13]	HAN Jiancun, ZHOU Yi. Effects of nobiletin on proliferation and apoptosis of laryngeal squamous cell carcinoma cells by regulating the FAK/AKT signaling pathway [J]. Tianjin Medical Journal, 2025, 53(6): 561-565.
[14]	MA Chunmei, YU Peng, ZHANG Qicheng, YANG Lei, LI Dihua, TAN Jian, MENG Zhaowei. Mechanism study of benzyl isothiocyanate combined with sorafenib in the treatment of anaplastic thyroid cancer [J]. Tianjin Medical Journal, 2025, 53(5): 449-455.
[15]	LI Chen, LI Zhan’en, SU Hongwei, HOU Caiyun, DONG Shaowen. Effects of KRT17 regulating Wnt/β-catenin signaling pathway on proliferation, apoptosis and epithelial mesenchymal transformation of bladder cancer cells [J]. Tianjin Medical Journal, 2025, 53(5): 462-467.

Research progress of CREB in angiogenesis, anti-apoptosis and lung cancer

Cite this article

PDF (PC)

Knowledge

Abstract

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments